Evaluation of cII mutations in lung of male Big Blue mice exposed by inhalation to vanadium pentoxide for up to 8 weeks

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 789-790, Issue , 2015, Pages 46-52

  Manjanatha, Mugimane G ^a   Shelton, Sharon D ^a   Haber, Lynne ^b,g   Gollapudi, Bhaskar ^c   MacGregor, Judith A ^d   Rajendran, Narayanan ^e   Moore, Martha M ^a,f  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b Toxicology Excellence for Risk Assessment   (United States)

^c EXPONENT INC   (United States)

^d Toxicology Consulting Services   (United States)

^e IIT RESEARCH INSTITUTE   (United States)

^f ENVIRON INTERNATIONAL CORPORATION   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CII mutagenicity in Big Blue mice; Mutagenic mode of action for the carcinogenicity of vanadium pentoxide; Vanadium pentoxide mutagenicity in lungs by inhalation study

Indexed keywords

GENOMIC DNA; VANADIUM PENTOXIDE; CII PROTEIN, BACTERIOPHAGE LAMBDA; TRANSCRIPTION FACTOR; VANADIUM DERIVATIVE; VIRUS PROTEIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B6C3F1 MOUSE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CII GENE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE; GENE MUTATION; GENOTOXICITY; IN VIVO STUDY; INFLAMMATION; INHALATION; LUNG CARCINOGENESIS; LUNG WEIGHT; MALE; MOUSE; MUTAGENICITY; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRANSGENIC MOUSE; X RAY DIFFRACTION; ANIMAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; GENETICS; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG TUMOR; METABOLISM; MUTAGEN TESTING; MUTATION; NUCLEOTIDE SEQUENCE; ORGAN SIZE; PATHOLOGY; TIME;

MUS;

ADMINISTRATION, INHALATION; ANIMALS; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; LUNG; LUNG NEOPLASMS; MALE; MICE, TRANSGENIC; MUTAGENICITY TESTS; MUTATION; ORGAN SIZE; TIME FACTORS; TRANSCRIPTION FACTORS; VANADIUM COMPOUNDS; VIRAL PROTEINS;

EID: 84938209085     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2015.06.014     Document Type: Article

References (28)

1. Ferlay J., Bray F., Pisani P., Parkin D.M. Globocan 2002. Cancer Incidence, Mortality and Prevalence Worldwide Lyon 2004, IARC Press, France.
2. Jemal R., Siegel E., Ward T., Murray J., Xu M.J.T. Cancer statistics. CA Cancer J. 2007, 57:43-66.
3. Pope C.A., Burnett R.T., Thun M.J., Calle E.E., Krewski D., Ito K., Thurston G.D. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287:1132-1141.
4. USEPA Air Quality Criteria for Particulate Matter (Final Report, October 2004) 2004, US Environmental Protection Agency, Washington DC, USA.
5. Lippmann M., Yeates D.B., Albert R.E. Deposition, retention, and clearance of inhaled particles. Br. J. Ind. Med. 1980, 37:337-362.
6. Galaris D., Evangelou A. The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit. Rev. Oncol. Hematol. 2002, 42:93-103.
7. Knaapen A.M., Borm P.J., Albrecht C., Schins R.P. Inhaled particles and lung cancer. Part A: mechanisms. Int. J. Cancer 2004, 109:799-809.
8. Saldiva P.H., Clarke R.W., Coull B.A., Stearns R.C., Lawrence J., Murthy G.G., Diaz E., Koutrakis P., Suh H., Tsuda A., Godleski J.J. Lung inflammation induced by concentrated ambient air particles is related to particle composition. Am. J. Respir. Crit. Care Med. 2002, 165:1610-1617.
9. Dreher K.L., Jaskot R.H., Lehmann J.R., Richards J.H., McGee J.K., Ghio A.J., Costa D.L. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J. Toxicol. Environ. Health 1997, 50:285-305.
10. IARC Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. IARC Monographs 2006, 86:1-294.
11. Hauser R., Eisen E.A., Pothier L., Christiani D.C. A prospective study of lung function among boilermaker construction workers exposed to combustion particulates. Am. J. Ind. Med. 2001, 39:454-462.
12. Ehrlich V.A., Nersesyan A.K., Hoelzi C., Ferk F., Bichler J., Valic E., Schaffer A., Schulte-Hermann R., Fenech M., Wagner K.H., Knasmuller S. Inhalative exposure to vanadium pentoxide causes DNA damage in workers. Results Multiple End Point Study Environ. Health Perspect. 2008, 116:1689-1693.
13. Boice J.D., Mumma M.T., Blot W.J. Cancer and noncancer mortality in populations living near uranium and vanadium mining and milling operations in Montrose County, Colorado, 1950-2000. Radiat. Res. 2007, 167:711-726.
14. NTP, Toxicology and Carcinogenesis Studies of Vanadium Pentoxide (CAS No. 1314-62-1) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) 2002, N.I.O.H. U.S. Department of Health and Human Services (Ed.), Research Triangle Park, NC.
15. Ress N.B., Chou B.J., Renne R.A., Dill J.A., Miller R.A., Roycroft J.H., Hailey J.R., Haseman J.K., Bucher J.R. Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol. Sci. 2003, 74:287-296.
16. Starr T.B., MacGregor J.A., Ehman K.D., Nikiforov A.I. Vanadium pentoxide: use of relevant historical control data shows no evidence for carcinogenic response in F344/N rats. Regul. Toxicol. Pharmacol. 2012, 64:155-160.
17. Rivedal E., Roseng L.E., Sanner T. Vanadium compounds promote the induction of morphological transformation of hamster embryo cells with no effect on gap junctional cell communication. Cell Biol. Toxicol. 1990, 6:303-314.
18. Rondini E.A., Walters D.M., Bauer A.K. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part. Fibre Toxicol. 2010, 7.
19. Altamirano-Lozano M., Valverde M., Alvarez B.L., Molina B., Rojas E. Genotoxic studies of vanadium pentoxide (V2O5) in male mice. II. Effects in several mouse tissues. Teratog. Carcinog. Mutagen. 1999, 19:243-255.
20. Rojas-Lemus M., Altamirano-Lozano M., Fortoul T.I. Sex differences in blood genotoxic and cytotoxic effects as a consequence of vanadium inhalation: micronucleus assay evaluation. J. Appl. Toxicol. 2014, 34:258-264.
21. Schuler D., Chevalier H.J., Merker M., Morgenthal K., Ravanat J.L., Sagelsdorff P., Walter M., Weber K., McGregor D. First steps towards an understanding of a mode of carcinogenic action for vanadium pentoxide. J. Toxicol. Pathol. 2011, 24:149-162.
22. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J. Biol. Chem. 1992, 267:166-172.
23. Banda M., McKim K.L., Haber L.T., MacGregor J.A., Gollapudi B.B., Parsons B.L. Quantification of K-ras mutant fraction in the lung DNA of mice exposed to aerosolized particulate vanadium pentoxide by inhalation. Mutat. Res. 2015, (in press).
24. Manjanatha M.G., Li-Wu L., Shelton S.D., Doerge D.R. Acrylamide-induced carcinogenicity in mouse lung involves mutagenicity: cII gene mutations in the lung of Big Blue mice exposed to acrylamide and glycidamide for up to 4 weeks. Environ. Mol. Mutagen. 2015, 56(5):446-456.
25. Cariello N.F., Piegorsch W.W., Adams W.T., Skopek T.R. Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 1994, 15:2281-2285.
26. Assem F.L., Levy S.L. A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health Part B 2009, 12:289-306.
27. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB 2003, 17:1195-1214.
28. Devereux T.R., Holliday W., Anna C., Ress N., Roycroft R.C. Sills, map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 2002, 23:1737-1743.